Correlation Between OS Therapies and Puma Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both OS Therapies and Puma Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OS Therapies and Puma Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OS Therapies Incorporated and Puma Biotechnology, you can compare the effects of market volatilities on OS Therapies and Puma Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OS Therapies with a short position of Puma Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of OS Therapies and Puma Biotechnology.

Diversification Opportunities for OS Therapies and Puma Biotechnology

-0.54
  Correlation Coefficient

Excellent diversification

The 3 months correlation between OSTX and Puma is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding OS Therapies Incorporated and Puma Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Puma Biotechnology and OS Therapies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OS Therapies Incorporated are associated (or correlated) with Puma Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Puma Biotechnology has no effect on the direction of OS Therapies i.e., OS Therapies and Puma Biotechnology go up and down completely randomly.

Pair Corralation between OS Therapies and Puma Biotechnology

Given the investment horizon of 90 days OS Therapies is expected to generate 1.61 times less return on investment than Puma Biotechnology. In addition to that, OS Therapies is 2.1 times more volatile than Puma Biotechnology. It trades about 0.02 of its total potential returns per unit of risk. Puma Biotechnology is currently generating about 0.06 per unit of volatility. If you would invest  260.00  in Puma Biotechnology on September 17, 2024 and sell it today you would earn a total of  28.00  from holding Puma Biotechnology or generate 10.77% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy98.46%
ValuesDaily Returns

OS Therapies Incorporated  vs.  Puma Biotechnology

 Performance 
       Timeline  
OS Therapies 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in OS Therapies Incorporated are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, OS Therapies may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Puma Biotechnology 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Puma Biotechnology are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady basic indicators, Puma Biotechnology demonstrated solid returns over the last few months and may actually be approaching a breakup point.

OS Therapies and Puma Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with OS Therapies and Puma Biotechnology

The main advantage of trading using opposite OS Therapies and Puma Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OS Therapies position performs unexpectedly, Puma Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Puma Biotechnology will offset losses from the drop in Puma Biotechnology's long position.
The idea behind OS Therapies Incorporated and Puma Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Money Managers
Screen money managers from public funds and ETFs managed around the world
Insider Screener
Find insiders across different sectors to evaluate their impact on performance